MDA435/LCC6 and MDA435/LCC6 MDR: ascites models of human breast cancer
1996

New Ascites Model for Breast Cancer Research

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): F Leonessa, D Green, T Licht, A Wright, K Wingate-Legette, J Lippman, MM Gottesman, R Clarke

Primary Institution: Georgetown University Medical School

Hypothesis

The MDA435/LCC6 ascites model can effectively mimic human breast cancer for drug screening.

Conclusion

The MDA435/LCC6 ascites model closely reflects the drug response patterns seen in untreated breast cancer patients.

Supporting Evidence

  • The MDA435/LCC6 cells grow as both malignant ascites and solid tumors in vivo.
  • Drug response patterns in the MDA435/LCC6 model reflect those seen in previously untreated breast cancer patients.
  • The model has a tumor incidence of approximately 100% in nude mice.

Takeaway

Scientists created a new model of breast cancer using special cells that grow in fluid in the belly, which helps them test new medicines.

Methodology

The study involved creating an ascites model from the MDA-MB-435 breast cancer cell line and testing its response to various cytotoxic drugs in vivo and in vitro.

Limitations

The model may not fully replicate all aspects of human breast cancer due to its specific cell line origin.

Participant Demographics

The parental MDA-MB-435 cells were derived from a 31-year-old Caucasian woman with metastatic breast cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication